Guardian Pharmacy Services (GRDN) Cost of Revenue (2023 - 2026)

Guardian Pharmacy Services has reported Cost of Revenue for 4 years, with the latest figure at $260.3 million in Q1 2026.

• Quarterly Cost of Revenue fell 1.76% year-over-year to $260.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.2 billion (up 11.92% YoY) and the FY2025 annual result came in at $1.2 billion, up 17.47% from the prior year.
• Cost of Revenue fell to $260.3 million in Q1 2026 per GRDN's latest filing, from $312.1 million in the prior quarter.
• Over five years, Cost of Revenue peaked at $312.1 million in Q4 2025 and troughed at $210.5 million in Q3 2023.
• A 4-year average of $257.9 million and a median of $260.3 million in 2026 frame the typical range for Cost of Revenue.
• The sharpest annual moves came in 2024 and 2026: Cost of Revenue grew 20.41% in 2024, then retreated 1.76% in 2026.
• Over 4 years, Cost of Revenue stood at $226.5 million in 2023, then climbed by 19.86% to $271.5 million in 2024, then increased by 14.97% to $312.1 million in 2025, then slipped by 16.61% to $260.3 million in 2026.
• According to Business Quant data, Cost of Revenue over the past three periods registered $260.3 million, $312.1 million, and $302.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.